Hospers GA - Search Results

1

Synthetic oligonucleotides: useful molecules? A review.

Calogero A, Hospers GA, Mulder NH. Calogero A, et al. Among authors: hospers ga. Pharm World Sci. 1997 Dec;19(6):264-8. doi: 10.1023/a:1008699515124. Pharm World Sci. 1997. PMID: 9443167 Review.

2

The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.

Hospers GA, de Vries EG, Mulder NH. Hospers GA, et al. Br J Cancer. 1990 Jan;61(1):79-82. doi: 10.1038/bjc.1990.18. Br J Cancer. 1990. PMID: 2153398 Free PMC article.

3

A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.

Hospers GA, Meijer C, de Leij L, Uges DR, Mulder NH, de Vries EG. Hospers GA, et al. Int J Cancer. 1990 Jul 15;46(1):138-44. doi: 10.1002/ijc.2910460125. Int J Cancer. 1990. PMID: 2163989

4

The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.

Meijer C, Mulder NH, Hospers GA, Uges DR, de Vries EG. Meijer C, et al. Among authors: hospers ga. Br J Cancer. 1990 Jul;62(1):72-7. doi: 10.1038/bjc.1990.232. Br J Cancer. 1990. PMID: 2390486 Free PMC article.

5

Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line.

Timmer-Bosscha H, Hospers GA, Meijer C, Mulder NH, Muskiet FA, Martini IA, Uges DR, de Vries EG. Timmer-Bosscha H, et al. Among authors: hospers ga. J Natl Cancer Inst. 1989 Jul 19;81(14):1069-75. doi: 10.1093/jnci/81.14.1069. J Natl Cancer Inst. 1989. PMID: 2544740

6

Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.

Hospers GA, Mulder NH, de Jong B, de Ley L, Uges DR, Fichtinger-Schepman AM, Scheper RJ, de Vries EG. Hospers GA, et al. Cancer Res. 1988 Dec 1;48(23):6803-7. Cancer Res. 1988. PMID: 2846161

7

Mechanisms of cellular resistance to cisplatin.

Hospers GA, Mulder NH, De Vries EG. Hospers GA, et al. Med Oncol Tumor Pharmacother. 1988;5(3):145-51. doi: 10.1007/BF02986437. Med Oncol Tumor Pharmacother. 1988. PMID: 3045443 Review.

8

[The use of genes in the treatment of cancer].

Hospers GA, Mulder NH. Hospers GA, et al. Ned Tijdschr Geneeskd. 1995 Jul 1;139(26):1316-9. Ned Tijdschr Geneeskd. 1995. PMID: 7617047 Dutch. No abstract available.

9

Long-term results of induction- and intensification chemotherapy supported with autologous bone marrow reinfusion in patients with disseminated or T4 breast cancer.

Mulder NH, Dolsma WV, Mulder PO, De Vries EG, Willemse PH, Sleijfer DT, Hospers GA, Van der Graaf WT. Mulder NH, et al. Among authors: hospers ga. Anticancer Res. 1995 Jul-Aug;15(4):1565-8. Anticancer Res. 1995. PMID: 7654046 Clinical Trial.

10

Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B.

Schröder CP, de Vries EG, Mulder NH, Willemse PH, Sleijfer DT, Hospers GA, van der Graaf WT. Schröder CP, et al. Among authors: hospers ga. J Antimicrob Chemother. 1999 May;43(5):741-3. doi: 10.1093/jac/43.5.741. J Antimicrob Chemother. 1999. PMID: 10382902 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page